The Scientist

» gold and disease/medicine

Most Recent

image: Upheaval Over Children’s Health Study

Upheaval Over Children’s Health Study

By | March 21, 2012

A second advisor for the National Children’s Study resigns in response to changes in study design.

0 Comments

image: Prometheus Patents Overturned

Prometheus Patents Overturned

By | March 20, 2012

The US Supreme Court ruled that two dose calibration methods from biotech company Prometheus Laboratories cannot be patented.

12 Comments

image: Teaching HIV/AIDS Denialism?

Teaching HIV/AIDS Denialism?

By | March 20, 2012

An Italian university is investigating whether a professor was right to teach a course denying a causal link between HIV and AIDS.

18 Comments

image: New African Bone Marrow Registry

New African Bone Marrow Registry

By | March 19, 2012

Nigeria launches its first ever bone marrow registry, which should make it easier to find matches for black people around the world.

0 Comments

image: HHMI Competition Opens

HHMI Competition Opens

By | March 16, 2012

The biomedical institute seeks up to 30 new investigators in its first nationwide search in 5 years.

0 Comments

image: Trouble at the CDC?

Trouble at the CDC?

By | March 12, 2012

Anonymous letters to The Lancet point to problems with the CDC's Center for Global Health, but the agency denies the allegations.

4 Comments

image: High Tumor Heterogeneity Confirmed

High Tumor Heterogeneity Confirmed

By | March 9, 2012

One biopsy may not provide enough information about the array of mutations in cancer to devise treatments based on a tumor’s genetic profile.

2 Comments

image: Origami Sensors

Origami Sensors

By | March 9, 2012

An inexpensive 3-D paper sensor could test for HIV and malaria.

2 Comments

image: H5N1 Insiders Speak Out

H5N1 Insiders Speak Out

By | March 6, 2012

NSABB and Congress members voice their opinions about the new developments in the H5N1 research debate.

0 Comments

image: Designer Aspirin Fights Cancer

Designer Aspirin Fights Cancer

By | March 5, 2012

Early experiments show that a hybrid form of the common pain reliever can effectively inhibit the growth of many tumor types.

0 Comments

Advertisement

Popular Now

  1. Opinion: Making Progress by Slowing Down
  2. Influential Cancer Biologist Dies
  3. Censored Professor Quits
    The Nutshell Censored Professor Quits

    Alice Dreger is resigning from the faculty of Northwestern University, claiming that the administration censored her work in a faculty journal.

  4. How Fats Influence the Microbiome
Advertisement
Advertisement
Life Technologies